KOL Identification & Mapping in Pharma & Biotech
KOL identification and mapping belong together: one finds the right experts, the other shows how they connect, influence each other and shape real‑world decisions across your markets. Our combined KOL identification and mapping service gives pharma and biotech teams a precise view of who matters in each therapy area and a rich, visual understanding of the networks, pathways and roles that sit behind each name.
What this service includes
Targeted KOL identification
We build a bespoke, therapy‑area specific definition of “KOL” for your brief – from global and regional thought leaders to local catalysts of change, trialists, digital opinion leaders and emerging experts. Using multi‑source data and internal inputs, we create a validated, prioritised expert list that reflects your strategy, lifecycle stage and markets.
Network‑level KOL mapping
Once the right experts are identified, we map how they relate to each other and to the wider stakeholder ecosystem, including investigators, guideline authors, referrers and patient organisations. Network maps reveal clusters, hubs and cross‑specialty bridges, helping you see scientific centres of gravity, referral pathways and where influence really flows.
Integrated qualitative and quantitative insight
Direct engagement (interviews, surveys, internal stakeholder input) adds depth to quantitative indicators like publications, trials, congress roles and digital reach. This combination allows us to confirm who is influential in practice, understand attitudes to new science and refine the KOL network to what genuinely matters for your objectives.
Segmentation, scoring and prioritisation
We apply structured scoring and segmentation across both identification and mapping outputs, creating clear tiers and segments such as scientific leaders, practice influencers, DOLs, catalysts of change and high‑potential emerging experts. This makes it easy for medical, commercial and clinical teams to see where to focus time and budget, by country, segment and channel.
Activation‑ready deliverables
Outputs are delivered as activation‑ready profiles, dashboards and map views that plug directly into engagement planning, advisory strategy, clinical collaboration and omnichannel programmes. We work with your teams to ensure KOL identification and mapping are embedded in your workflows, so the insights move quickly from slides to practical action.
Speak to us about how we can
help you identify the people who can most strongly impact the success of your brand and evidence strategy.